Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Comment by Tuco110on Dec 09, 2019 1:41pm
105 Views
Post# 30436519

RE:RE:Condensate was $82.28 today

RE:RE:Condensate was $82.28 todayRuud, you keep refering back to the hedging program as a drag on revenue growth. Remember that the hedging is not at base model prices of $70 but closer to $78. You seem to be forgeting that even at hedged prices the company is making more than forecast in their production models. I agree that if condensate prices continue to raise it will result in commodity impairment charges on the financials but those are non cash accounting adjustments that don't affect cashflow. I personally would love to see impaiment charges that account for $120 condensate.
<< Previous
Bullboard Posts
Next >>